Expanding Horizons in Diabetic Care: The Role of Empagliflozin in Evolving Therapies

What Will You Learn?

• Understand the unique mechanism of action of empagliflozin as an SGLT2 inhibitor and its metabolic effects.
• Examine empagliflozin’s efficacy in lowering HbA1c, weight reduction, and blood pressure control.
• Explore its role in reducing cardiovascular mortality, heart failure hospitalizations, and renal protection.
• Identify ideal candidates for empagliflozin therapy based on comorbidities (e.g., heart failure, CKD).
• Address safety considerations, including DKA risk, genital mycotic infections, and volume depletion.
• Develop strategies for combining empagliflozin with other antidiabetic agents (e.g., GLP-1 RAs, metformin).